Proper Name: Zoster Vaccine Recombinant, Adjuvanted
Manufacturer: GlaxoSmithKline Biologicals
• Indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older.
- Package Insert - SHINGRIX
- Demographic Subgroup Information - Zoster Vaccine Recombinant, Adjuvanted (SHINGRIX)
Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.